Precision cancer imaging · Helsinki, Finland

Unlocking the next generation of imaging agents for precision diagnosis.

Finding cancer early changes everything. We're building the next generation of imaging agents to help doctors see it sooner and with more precision.

Our mission
Building the next-generation platform for precision cancer diagnostics and therapeutics.
What we do

One platform. Many new imaging agents.

Today's imaging agents are either easy to make but short-lived, or precise and long-lasting but hard to make without damaging the molecule. We remove that tradeoff.

Precise and longer-lasting

Sharper images, and agents that last long enough to reach hospitals across a region.

Gentle on delicate molecules

Keeps the targeting molecule intact, so it still finds what it was designed to find.

Fits existing facilities

Designed to work with the equipment imaging centres already use.

Pipeline of new imaging agents, with lead programmes progressing toward first-in-human studies.
Work with us

Open to early adopters and collaborators.

If you're working in cancer imaging, research or development, let's talk.

Get in touch
Our team

The inventors run the company.

Two scientists who built the technology, and a commercial lead taking it to market.

Sofia Otaru

Sofia Otaru, PhD

CEO

Expert in designing new imaging agents. Leads scientific and regulatory strategy.

Andreas Paulus

Andreas Paulus, PhD

CTO

Experience in clinical imaging agent production and the chemical industry. Leads technical development.

Khalil Elbadri

Khalil Elbadri

CBO

Background in drug delivery and translational research projects. Leads commercial strategy, partnerships and fundraising.

Advisors
Kim Bergström
Kim Bergström, PhDFormer Head of Cyclotron Unit, Helsinki University Hospital
Anu Airaksinen
Prof. Anu AiraksinenRadiopharmaceutical chemistry
Tiina Sikanen
Prof. Tiina SikanenPharmacometabolomics
Contact

Let's talk.

Investors, partners and collaborators: we'd like to hear what you're working on.